Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

298 ARTÍCULOS , VIENDO DEL 151 AL 165

(18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic Neurons

Hefti FF, Kung HF, Kilbourn MR, Carpenter AP, Clark CM, Skovronsky DM.

PET Clin. 2010 Jan;5(1):75-82. doi: 10.1016/j.cpet.2010.02.001. Epub 2010 May 27.

Neurotransmission in Parkinson's disease: beyond dopamine

Barone P.

Eur J Neurol. 2010 Mar;17(3):364-76. doi: 10.1111/j.1468-1331.2009.02900.x. Epub 2009 Dec 30.

Complications and side effects of deep brain stimulation in the posterior subthalamic area

Fytagoridis A, Blomstedt P.

Stereotact Funct Neurosurg. 2010;88(2):88-93. doi: 10.1159/000271824. Epub 2010 Jan 5.

Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research

Knol W, Keijsers CJ, Jansen PA, van Marum RJ.

J Clin Psychopharmacol. 2010 Feb;30(1):57-63. doi: 10.1097/JCP.0b013e3181c914b3.

Treadmill training for patients with Parkinson's disease

Mehrholz J, Friis R, Kugler J, Twork S, Storch A, Pohl M.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007830. doi: 10.1002/14651858.CD007830.pub2.

Sleep disturbances in Parkinson disease and their potential role in heterogeneity

Gunn DG, Naismith SL, Lewis SJ.

J Geriatr Psychiatry Neurol. 2010 Jun;23(2):131-7. doi: 10.1177/0891988709358591. Epub 2010 Jan 25.

C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease

Harrington AJ, Hamamichi S, Caldwell GA, Caldwell KA.

Dev Dyn. 2010 May;239(5):1282-95. doi: 10.1002/dvdy.22231.

[Experience with 123I-Iodobenzamide in the differential diagnosis of Parkinson's disease and Parkinson-plus disease]

Paniagua Correa C, García Alonso P, Balsa Bretón MA, Mariana Monguía A, Penín González FJ, Pey Illera C.

Rev Esp Med Nucl. 2010 Mar-Apr;29(2):57-62. doi: 10.1016/j.remn.2009.12.008. Epub 2010 Feb 4.

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

Louis ED, Ferreira JJ.

Mov Disord. 2010 Apr 15;25(5):534-41. doi: 10.1002/mds.22838.

Novel CDNF/MANF family of neurotrophic factors

Lindholm P, Saarma M.

Dev Neurobiol. 2010 Apr;70(5):360-71. doi: 10.1002/dneu.20760.

Behavioral phenotyping of mouse models of Parkinson's disease

Taylor TN, Greene JG, Miller GW.

Behav Brain Res. 2010 Jul 29;211(1):1-10. doi: 10.1016/j.bbr.2010.03.004. Epub 2010 Mar 6.

Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases

Treglia G, Cason E, Gabellini A, Giordano A, Fagioli G.

Neurol Sci. 2010 Aug;31(4):417-22. doi: 10.1007/s10072-010-0239-z. Epub 2010 Mar 10.

Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations

Colosimo C, Martínez-Martín P, Fabbrini G, Hauser RA, Merello M, Miyasaki J, Poewe W, Sampaio C, Rascol O, Stebbins GT, Schrag A, Goetz CG.

Mov Disord. 2010 Jul 15;25(9):1131-42. doi: 10.1002/mds.23072.

Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages

Virués-Ortega J, Rodríguez-Blázquez C, Micheli F, Carod-Artal FJ, Serrano-Dueñas M, Martínez-Martín P.

Mov Disord. 2010 Jul 30;25(10):1391-8. doi: 10.1002/mds.23081.

Early diagnosis of Parkinson's disease: recommendations from diagnostic clinical guidelines

Pahwa R, Lyons KE.

Am J Manag Care. 2010 Mar;16 Suppl Implications:S94-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias